Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,385
Closed -$407K 165
2026
Q1
$407K Sell
3,385
-4,958
-59% -$572K 0.14% 102
2025
Q4
$878K Buy
+8,343
New +$783K 0.18% 111
2025
Q3
Sell
-21,680
Closed -$1.72M 350
2025
Q2
$1.72M Buy
21,680
+11,062
+104% +$879K 0.5% 48
2025
Q1
$953K Buy
+10,618
New +$991K 0.29% 96
2024
Q1
Sell
-16,605
Closed -$1.81M 159
2023
Q4
$1.81M Buy
16,605
+6,265
+61% +$650K 0.69% 41
2023
Q3
$1.06M Sell
10,340
-13,882
-57% -$1.5M 0.44% 56
2023
Q2
$2.79M Buy
24,222
+23,813
+5,822% +$2.7M 0.79% 23
2023
Q1
$10M Sell
409
-9,385
-96% -$1.01M 0.06% 130
2022
Q4
$1.09M Buy
9,794
+9,436
+2,636% +$965K 0.36% 44
2022
Q3
$30K Sell
358
-120
-25% -$10.7K 0.03% 134
2022
Q2
$43K Buy
478
+190
+66% +$16.8K 0.03% 128
2022
Q1
$23K Sell
288
-48
-14% -$3.78K 0.02% 88
2021
Q4
$25K Buy
+336
New +$26.8K 0.02% 76
2021
Q3
Sell
-327
Closed -$25K 95
2021
Q2
$25K Sell
327
-16
-5% -$1.19K 0.02% 61
2021
Q1
$25K Buy
+343
New +$25.3K 0.02% 58

Other funds holding MRK

Mach-1 Financial Group's MRK Position: Q2 2026 in Review

Mach-1 Financial Group sold out of Merck (MRK) in Q2 2026, closing a stake of 3,385 shares — an estimated $407K sold.

Mach-1 Financial Group first reported a position in MRK in Q1 2021 and held it in 15 quarters. The position peaked at $10M in Q1 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mach-1 Financial Group reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 3,385 Merck shares in Q2 2026, an estimated $407K.
  • Mach-1 Financial Group first reported a position in Merck in Q1 2021 and held it in 15 quarters.
  • Mach-1 Financial Group's Merck position peaked at $10M in Q1 2023.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mach-1 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.